SMC1A and colorectal carcinoma: Furthermore, it was suggested that reducing SMC1 expression could reduce proliferation, increase apoptosis, and enhance sensitivity to oxaliplatin in CRC cells, suggesting that SMC1 may become a new target for the prognosis and treatment of CRC.15, 16